The BRCA2 mutation status shapes the immune phenotype of prostate cancer
2019 · Cancer Immunology Immunotherapy · 52 citations
https://doi.org/10.1007/s00262-019-02393-x
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
52
Citations
1
h-index
1
i10-index
Peter Keß is an academic researcher from Heidelberg University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Prostate Cancer Treatment and Research & Immunotherapy and Immune Responses. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat